Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuntius Therapeutics
London, England, United Kingdom
- Ownership
- Private
- Employees
- ~2
- Development stage
- Preclinical
01
Overview
Nuntius Therapeutics develops programmable, cell-specific mRNA therapies using proprietary non-immunogenic nanocarriers that outperform leading delivery technologies. Their pipeline targets cancer, lung diseases, and neurodegenerative disorders. The company leverages machine learning to optimize carrier selection from millions of candidates. They have recently entered a collaboration with Taiho Pharmaceutical for oncology-focused mRNA immunotherapies. No clinical results or human trial data are yet available.
- Therapeutic areas
- OncologyPulmonologyNeurology
- Modalities
- mRNA therapeuticsGene editing therapiesNanocarrier-based delivery systemsPeptide dendrimer and lipid-based nanocarriers
- Industry
- Biotech
02
Partnerships
Taiho Pharmaceutical Co., Ltd.—collaboration on next-generation oncology-focused mRNA immunotherapies using Nuntius’ proprietary cell-specific delivery technology.
Beyond the preview
Go deeper on Nuntius Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuntius Therapeutics.